Trial document
This study has been imported from ClinicalTrials.gov without additional data checks.
DRKS00006859
Trial Description
Title
Pulmonary Wedge Resection Plus Parietal Pleurectomy (WRPP) Versus Parietal Pleurectomy (PP) for the Treatment of Recurrent Primary Pneumothorax
Trial Acronym
WOPP
URL of the Trial
[---]*
Brief Summary in Lay Language
Primary spontaneous pneumothoraces (PSP) represent a significant public health problem,
occurring in young healthy subjects without pre-existing lung disease or precedent medical
intervention or trauma with a reported incidence of up to 18-28/100 000 per year. PSP
treatment often requires thoracic surgery to restore lung expansion and to prevent de novo
lung collapse. Despite the presence of elaborated guidelines by the British Thoracic Society
(BTS) postulating apical wedge resection of the lung and total parietal pleurectomy (WRPP),
the majority of German hospitals gathered experience especially in limiting surgery to
cost-saving partial apical parietal pleurectomy or yet apical pleural abrasion (PP). Until
today, hardly any reliable data exist to analyze and compare the varying treatment
approaches regarding efficacy and efficiency. In this randomized, multi-centric clinical
trial, both treatment approaches will be compared. For this purpose, candidates for surgery
will be randomized into one of the two treatment groups after informed consent has been
obtained. Patients will be followed for 2 years by the participating centres to be able to
evaluate the long-term effect of the surgical interventions.
Brief Summary in Scientific Language
The trial will be conducted at the major thoracic surgery units in Germany. Each centre can
include patients on the basis of the presence of a PSP and the inclusion and exclusion
criteria.
After informed consent has been obtained from the study participants, each has to fill out
the standardized short-form health survey (SF-36) questionnaire and the visual analogue
scale (VAS) to determine baseline parameters for the (current) state of health and pain
level.Randomization into the two interventional groups is carried out before surgery.
Patients are operated according to good clinical practice either by pleurectomy alone (PP)
or total parietal pleurectomy with apical wedge resection of the pulmonary apex (WRPP).
Procedure related parameters (like operation time, applied suture materials including
staplers) are documented.
The postoperative care is subject to each participating centre's standards. The
postoperative course is evaluated (mortality, morbidity, duration of tube drainage,
re-interventions or operations, length of stay, need for blood substitutions).
To evaluate the long term effect of the surgical intervention, all study participants are
followed for 2 years.
Organizational Data
- DRKS00006859
- 2014/10/09
- 2013/05/06
- yes
- [---]*
- [---]*
Secondary IDs
- NCT01855464 (ClinicalTrials.gov)
- UKW-TCH-2013-001 (Wuerzburg University Hospital)
- German Research Foundation
Health Condition or Problem studied
- Pneumothorax
- Recurrent Pneumothorax
- J93 - Pneumothorax
Interventions/Observational Groups
- Procedure: wedge resection
- Procedure: parietal pleurectomy
Characteristics
- Interventional
- [---]*
- Randomized controlled trial
- Blinded
- patient/subject
- Active control
- Treatment
- Parallel
- N/A
- [---]*
Primary Outcome
- Recurrence rate of primary pneumothorax following VAT surgery; time frame: 2 years; Patients are followed to identify all incidents of recurrent lung collapse following VAT surgery. Suspected recurrences will be confirmed by chest X-ray.
Secondary Outcome
- postoperative morbidity; time frame: 30 days
- postoperative pain; time frame: 7 days
- quality of life; time frame: 2 years
- costs of treatment; time frame: up to 30 days
Countries of Recruitment
- Germany
Locations of Recruitment
Recruitment
- [---]*
- 2013/11/30
- 360
- Multicenter trial
- National
Inclusion Criteria
- Both, male and female
- 15 Years
- 40 Years
Additional Inclusion Criteria
- recurrence of a primary pneumothorax
- persistent primary pneumothorax
- patient preference (in primary events)
Exclusion Criteria
- presence of a pulmonal fistula
- underlying lung disease
- previous thoracic surgery (except tube thoracostomy)
- previous pleurodesis
- conversion thoracotomy
Addresses
-
start of 1:1-Block address primary-sponsor
- Wuerzburg University Hospital
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address other
- German Research Foundation
end of 1:1-Block address otherstart of 1:1-Block address contact other- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact other -
start of 1:1-Block address other
- German Federal Ministry of Education and Research
end of 1:1-Block address otherstart of 1:1-Block address contact other- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact other -
start of 1:1-Block address scientific-contact
- Wuerzburg University Hospital
- Thorsten Walles, MD
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- Thorsten Walles, MD
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- +49 (0)931 201
- [---]*
- Walles_T at ukw.de
- [---]*
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- Bitte wenden Sie sich an den Sponsor / Please refer to primary sponsor
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- [---]*
- [---]*
- [---]*
- [---]*
end of 1:1-Block address contact materialSupport
Status
- Recruiting ongoing
- [---]*
Trial Publications, Results and other Documents
- Click here for information on German Research Foundation Grant
- Official Trial Website
- Henry M, Arnold T, Harvey J; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of spontaneous pneumothorax. Thorax. 2003 May;58 Suppl 2:ii39-52. No abstract available.; 12728149
- Chan JW, Ko FW, Ng CK, Yeung AW, Yee WK, So LK, Lam B, Wong MM, Choo KL, Ho AS, Tse PY, Fung SL, Lo CK, Yu WC. Management of patients admitted with pneumothorax: a multi-centre study of the practice and outcomes in Hong Kong. Hong Kong Med J. 2009 Dec;15(6):427-33.; 19966346
- Gossot D, Galetta D, Stern JB, Debrosse D, Caliandro R, Girard P, Grunenwald D. Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax. Surg Endosc. 2004 Mar;18(3):466-71. Epub 2004 Feb 2. Review.; 14752638
- 2
- 2014/10/07